• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retraction notice to "Statistical optimization of hyaluronidase production by Ochrobactrum intermedium MEFS strain along with in vivo application in the treatment of aesthetic filler complications" [Int. J. Biol. Macromol. 289 (2025) 138383].

作者信息

Mohammed Fafy A, Ebraheem Mai A, El-Fakharany Esmail M, Husseiny Sherif Moussa

机构信息

Botany Department, Faculty of Women for Arts, Science and Education, Ain Shams University, Egypt.

Protein Research Department, Genetic Engineering and Biotechnology Research Institute GEPRI, City of Scientific Research and Technological Applications (SRTA-City), New Borg Al Arab, 21934 Alexandria, Egypt; Pharmaceutical and Fermentation Industries Development Centre (PFIDC), City of Scientific Research and Technological Applications (SRTA-City), New Borg Al Arab, 21934 Alexandria, Egypt; Pharos University in Alexandria, Canal El Mahmoudia Street, Beside Green Plaza Complex, 21648 Alexandria, Egypt.

出版信息

Int J Biol Macromol. 2025 Jul;318(Pt 3):145577. doi: 10.1016/j.ijbiomac.2025.145577. Epub 2025 Jul 11.

DOI:10.1016/j.ijbiomac.2025.145577
PMID:40645902
Abstract
摘要

相似文献

1
Retraction notice to "Statistical optimization of hyaluronidase production by Ochrobactrum intermedium MEFS strain along with in vivo application in the treatment of aesthetic filler complications" [Int. J. Biol. Macromol. 289 (2025) 138383].撤回通知：“中间苍白杆菌MEFS菌株透明质酸酶生产的统计优化及其在治疗美容填充剂并发症中的体内应用”[《国际生物大分子杂志》289卷（2025年）138383]
Int J Biol Macromol. 2025 Jul;318(Pt 3):145577. doi: 10.1016/j.ijbiomac.2025.145577. Epub 2025 Jul 11.
2
Statistical optimization of hyaluronidase production by Ochrobactrum intermedium MEFS strain along with in vivo application in the treatment of aesthetic filler complications.
Int J Biol Macromol. 2025 Feb;289:138383. doi: 10.1016/j.ijbiomac.2024.138383. Epub 2024 Dec 6.
3
Retraction notice to "Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis" [Int. J. Biol. Macromol. 95 (2017) 438-450].
Int J Biol Macromol. 2025 Aug;319(Pt 1):145891. doi: 10.1016/j.ijbiomac.2025.145891. Epub 2025 Jul 18.
4
Retraction notice to "Glycerol-silica/chitosan conjugated self-assembled nano-flower framework for Herstulla thompsoni delivery with effectiveness in natural settings: Optimization and pilot scale production" [Int. J. Biol. Macromol. 283 (2024) 137476].撤回通知：“用于在自然环境中递送汤普森赫斯特菌的甘油-二氧化硅/壳聚糖共轭自组装纳米花框架：优化与中试规模生产”[《国际生物大分子杂志》283卷（2024年）137476页]
Int J Biol Macromol. 2025 Aug;319(Pt 1):145890. doi: 10.1016/j.ijbiomac.2025.145890. Epub 2025 Jul 19.
5
Retraction notice to "Intratumoral delivery of mitomycin C using bio-responsive Gellan gum nanogel: In-vitro evaluation and enhanced chemotherapeutic efficacy" [Int. J. Biol. Macromol. 302 (2025) 140306].
Int J Biol Macromol. 2025 Jul;318(Pt 3):145559. doi: 10.1016/j.ijbiomac.2025.145559. Epub 2025 Jul 11.
6
A rare and first report of Ochrobactrum intermedium co-infection in coxsackievirus-A24-infected acute hemorrhagic conjunctivitis patients.中间苍白杆菌与柯萨奇病毒A24共同感染急性出血性结膜炎患者的罕见首例报告
Folia Microbiol (Praha). 2025 Jul 14. doi: 10.1007/s12223-025-01300-5.
7
Retraction notice to "Antibacterial, anticoagulant and cytotoxic evaluation of biocompatible nanocomposite of chitosan loaded green synthesized bioinspired silver nanoparticles" [Int. J. Biol. Macromol. 160 (2020) 934-943].
Int J Biol Macromol. 2025 Jul;318(Pt 1):144738. doi: 10.1016/j.ijbiomac.2025.144738. Epub 2025 Jun 27.
8
Effectiveness of retrobulbar hyaluronidase in the treatment of visual loss caused by periocular hyaluronic acid injection. A systematic review.玻璃体内注射透明质酸酶治疗眶周注射透明质酸致视力丧失的疗效：系统评价。
Arch Soc Esp Oftalmol (Engl Ed). 2022 Sep;97(9):521-538. doi: 10.1016/j.oftale.2022.06.005. Epub 2022 Jul 2.
9
Retraction notice to "Novel silk protein/hyaluronic acid hydrogel loaded with azithromycin as an immunomodulatory barrier to prevent postoperative adhesions" [Int. J. Biol. Macromol. 235 (2023) 123811].撤回通知：“新型载阿奇霉素的丝蛋白/透明质酸水凝胶作为免疫调节屏障预防术后粘连” [《国际生物大分子杂志》235 (2023) 123811]
Int J Biol Macromol. 2025 Jul;318(Pt 3):145578. doi: 10.1016/j.ijbiomac.2025.145578. Epub 2025 Jul 11.
10
Retraction notice to "Metal-amplified sonodynamic therapy of Ti-based chitosan-polyvinyl alcohol hybrid hydrogel dressing against subcutaneous Staphylococcus aureus infection" [Int. J. Biol. Macromol. 258 (2024) 129120].撤回通知：“基于钛的壳聚糖-聚乙烯醇混合水凝胶敷料对皮下金黄色葡萄球菌感染的金属增强声动力疗法”[《国际生物大分子杂志》258 (2024) 129120]
Int J Biol Macromol. 2025 Jul;318(Pt 1):144737. doi: 10.1016/j.ijbiomac.2025.144737. Epub 2025 Jun 27.